To be included, studies had to involve patients with a diagnosis of IIH according to established diagnostic (including modified Dandy or Friedman criteria) [16], administer a GLP-1 RA as an intervention, and report outcomes of interest such as ICP/CSF opening pressure, headache frequency/severity, visual function, weight/BMI, cognitive measures, and/or safety outcomes
Gastrointestinal Tolerance of D-Allulose in Healthy and Diabetic Subjects
Originally approved for type 2 diabetes and later for obesity treatment, GLP-1 and other incretin-based therapies have rapidly gained traction in both clinical and consumer spaces
An increase in ROS results in the activation of the cellular defense mechanism against lipid oxidation to eliminate ROS [38]
What I appreciate most is the professionalism of the office